Table of contents

Extended reports

• Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis (5 October, 2007)

  M-C Kastrinaki, P Sidiropoulos, S Roche, J Ringe, S Lehmann, H Kritikos, V-M Vlahava, B Delorme, G D Eliopoulos, C Jorgensen, P Charbord, T Häupl, D T Boumpas, H A Papadaki
• Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse (20 July, 2007)

  C H Burgoyne, S L Field, A K Brown, E M Hensor, A English, S L Bingham, R Verburg, U Fearon, C A Lawson, P J Hamlin, L Straszynski, D Veale, P Conaghan, M A Hull, J M van Laar, A Tennant, P Emery, J D Isaacs, F Ponchel
• Cervical interspinous bursitis in active polymyalgia rheumatica (21 January, 2008) Free

  C Salvarani, L Barozzi, F Cantini, L Niccoli, L Boiardi, M Valentino, N Pipitone, G Bajocchi, P Macchioni, M G Catanoso, I Olivieri, G G Hunder
• Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis (26 October, 2007)

  E Smolewska, J Stańczyk, H Brózik, M Biernacka-Zielińska, B Cebula, T Robak, P Smolewski
• A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis (26 October, 2007)

  A H M van der Helm-van Mil, S M van der Kooij, C F Allaart, R E M Toes, T W J Huizinga
• High-dose cyclophosphamide without stem cell rescue in scleroderma (1 November, 2007)

  C V Tehlirian, L K Hummers, B White, R A Brodsky, F M Wigley
• Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists (29 November, 2007)

  L Gossec, M Dougados, C Phillips, M Hammoudeh, K de Vlam, K Pavelka, T Pham, J Braun, J Sieper, I Olivieri, D van der Heijde, E Collantes, M Stone, T K Kvien, on behalf of ASAS (ASsessment in AS international working group)
• Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment (1 November, 2007)

  M M Veehof, P M ten Klooster, E Taal, P L C M van Riel, M A F J van de Laar
• Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression (2 November, 2007)

  E A Haavardsholm, P Bøyesen, M Østergaard, A Schildvold, T K Kvien
• Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis (1 November, 2007)

  D S Majka, K D Deane, L A Parrish, A A Lazar, A E Barón, C W Walker, M V Rubertone, W R Gilliland, J M Norris, V M Holers
• Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials (27 September, 2007)

  J Avouac, J Wipff, A Kahan, Y Allanore
• Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study (18 September, 2007)

  M L Hetland, K Stengaard-Pedersen, P Junker, T Lottenburger, I Hansen, L S Andersen, U Tarp, A Svendsen, J K Pedersen, H Skjødt, U B Lauridsen, T Ellingsen, G V O Hansen, H Lindegaard, A Vestergaard, A G Jurik, M Østergaard, K Hørslev-Petersen, the CIMESTRA study group
• Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis (20 July, 2007)

  M Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, H M J Hulsmans, W M de Beus, K H Han, F C Breedveld, B A C Dijkmans, C F Allaart, W F Lems
• Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV) (17 September, 2007)

  R M Andrade, G S Alarcón, L A González, M Fernández, M Apte, L M Vilá, G McGwin, J D Reveille, for the LUMINA Study Group
• Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus (29 August, 2007)

  S Jiménez, D Tàssies, G Espinosa, Á García-Criado, J Plaza, J Monteagudo, R Cervera, J C Reverter
• A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus (17 September, 2007)

  S A Wright, F M O’Prey, M T McHenry, W J Leahey, A B Devine, E M Duffy, D G Johnston, M B Finch, A L Bell, G E McVeigh
• Epistasis between the MHC and the RCAα block in primary Sjögren syndrome (18 September, 2007)

  S Lester, C McLure, J Williamson, P Bardy, M Rischmueller, R L Dawkins
• A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis (7 September, 2007)

  V Ravindran, D L Scott, E H Choy
• Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors (20 July, 2007)

  K T Jørgensen, A Wiik, M Pedersen, C J Hedegaard, B F Vestergaard, R E Gislefoss, T K Kvien, J Wohlfahrt, K Bendtzen, M Frisch
• Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse (6 September, 2007)

  K Komura, M Fujimoto, K Yanaba, T Matsushita, Y Matsushita, M Horikawa, F Ogawa, K Shimizu, M Hasegawa, K Takehara, S Sato
• BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000 (22 May, 2007) Free

  C-S Yee, D A Isenberg, A Prabu, K Sokoll, L-S Teh, A Rahman, I N Bruce, B Griffiths, M Akil, N McHugh, D D’Cruz, M A Khamashta, P Maddison, A Zoma, C Gordon